Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

SA Gayther, W Warren, S Mazoyer, PA Russell… - Nature …, 1995 - nature.com
SA Gayther, W Warren, S Mazoyer, PA Russell, PA Harrington, M Chiano, S Seal…
Nature genetics, 1995nature.com
Mutations in the BRCA1 gene, discovered in 1994, are associated with an 80–90% lifetime
risk of breast cancer. We have analysed 60 families with a history of breast and/or ovarian
cancer for germline mutations in BRCA1. Twenty–two different mutations were detected in
32 families (53%), of which 14 are previously unreported. We observed a significant
correlation between the location of the mutation in the gene and the ratio of breast to ovarian
cancer incidence within each family. Our data suggest a transition in risk such that mutations …
Abstract
Mutations in the BRCA1 gene, discovered in 1994, are associated with an 80–90% lifetime risk of breast cancer. We have analysed 60 families with a history of breast and/or ovarian cancer for germline mutations in BRCA1. Twenty–two different mutations were detected in 32 families (53%), of which 14 are previously unreported. We observed a significant correlation between the location of the mutation in the gene and the ratio of breast to ovarian cancer incidence within each family. Our data suggest a transition in risk such that mutations in the 3′ third of the gene are associated with a lower proportion of ovarian cancer. Haplotype analysis supports previous data which suggest some BRCA1 mutation carriers have common ancestors; however, we have found at least two examples where recurrent mutations appear to have arisen independently.
nature.com